Neisseria Meningitidis Group W-135 Capsular Polysaccharide Antigen Uses, Dosage, Side Effects and more
Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
| Trade Name | Neisseria Meningitidis Group W-135 Capsular Polysaccharide Antigen |
| Generic | Meningococcal polysaccharide vaccine group W-135 |
| Meningococcal polysaccharide vaccine group W-135 Other Names | Meningococcal polysaccharide antigen group W-135, neisseria meningitidis group W-135 capsular polysaccharide antigen, Neisseria meningitidis group W-135 polysaccharide antigen, A |
| Type | |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
